Deron Ricks, PA
Physician Assistant · Idaho Falls, IDNPI 1639156573
Payments from drug & device makers
Across 218 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$997
- Axsome Therapeutics, Inc.$285
- Astellas Pharma US Inc$278
- Lilly USA, LLC$204
- Vanda Pharmaceuticals Inc.$174
- GSK$172
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,858100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 54 | $997 |
| Axsome Therapeutics, Inc. | 16 | $285 |
| Astellas Pharma US Inc | 14 | $278 |
| Lilly USA, LLC | 15 | $204 |
| Vanda Pharmaceuticals Inc. | 7 | $174 |
| GSK | 10 | $172 |
| Otsuka America Pharmaceutical, Inc. | 8 | $162 |
| AstraZeneca(2 entities) | 10 | $159 |
| Johnson & Johnson | 10 | $149 |
| Novo Nordisk | 9 | $140 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $129 |
| Amgen | 6 | $93 |
| Phathom Pharmaceuticals, Inc. | 5 | $82 |
| Stryker | 1 | $80 |
| Pfizer | 5 | $74 |
| Sanofi-aventis U.S. LLC | 5 | $73 |
| Boston Scientific | 4 | $66 |
| Edwards Lifesciences | 3 | $55 |
| Boehringer Ingelheim | 3 | $47 |
| Exact Sciences | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Acadia Pharmaceuticals Inc | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 3 | $36 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Bayer | 2 | $28 |
| Insulet Corporation | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Biogen | 1 | $17 |
| Corium, LLC | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$3,858 in reported general payments places this provider in the 90th percentile of 1,027 physician assistant providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $35,508 |
| OzempicSemaglutide | 22 | $28,162 |
| MounjaroTirzepatide | 22 | $24,458 |
| JardianceEmpagliflozin | 11 | $8,823 |
| Buprenorphine | 18 | $8,561 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,557 |
| LinzessLinaclotide | 11 | $6,143 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 47 | $4,562 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 40 | $3,713 |
| Solifenacin Succinate | 15 | $3,568 |
| Celecoxib | 25 | $3,400 |
| Pregabalin | 21 | $2,990 |
| Fluticasone Propionate HfaFluticasone Propionate | 11 | $2,577 |
| Levothyroxine Sodium | 248 | $2,439 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 106 | $1,913 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $74 | $35,50854 claims |
| Novo NordiskOzempic | $140 | $28,16222 claims |
| Lilly USA, LLCMounjaro | $204 | $24,45822 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $47 | $15,38123 claims |
| AbbVieLinzess, Synthroid | $997 | $6,65624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,027 physician assistant providers in Idaho.
Other physician assistant in Idaho Falls
- Tyler PondIdaho Falls$13K
- Jed WillardsonIdaho Falls$12K
- Joshua KillpackIdaho Falls$11K
- Phillip MarloweIdaho Falls$10K
- Tyson ParkerIdaho Falls$10K
- Rebecca NewbyIdaho Falls$9K
- Todd CranorIdaho Falls$9K
- Lindsi GordonIdaho Falls$9K
- Amanda ColemanIdaho Falls$7K
- Alan AdamsIdaho Falls$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.